Cyclacel Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cyclacel Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2011 to Q3 2024.
  • Cyclacel Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $107K, a 72.6% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $822K, a 46.5% decline year-over-year.
  • Cyclacel Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.47M, a 2.19% decline from 2022.
  • Cyclacel Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.51M, a 30.2% increase from 2021.
  • Cyclacel Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.16M, a 169% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $822K $107K -$283K -72.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $1.11M $189K -$170K -47.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $1.28M $203K -$198K -49.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.47M $323K -$64K -16.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $1.54M $390K +$1K +0.26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.54M $359K +$9K +2.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $1.53M $401K +$21K +5.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $1.51M $387K +$82K +26.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $1.42M $389K +$70K +21.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-29
Q2 2022 $1.35M $350K +$72K +25.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.28M $380K +$125K +49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.16M $305K +$165K +118% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-11-29
Q3 2021 $992K $319K +$206K +182% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $786K $278K +$192K +223% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $594K $255K +$164K +180% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $430K $140K +$35K +33.3% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 $395K $113K -$71K -38.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $466K $86K -$6K -6.52% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $472K $91K +$6K +7.06% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $466K $105K +$29K +38.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $437K $184K +$96K +109% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $341K $92K +$6K +6.98% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $335K $85K +$4K +4.94% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $331K $76K +$10K +15.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-05
Q3 2018 $321K $88K +$23K +35.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $298K $86K +$20K +30.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 $278K $81K +$12K +17.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $266K $66K -$104K -61.2% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 $370K $65K -$127K -66.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $497K $66K -$133K -66.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $630K $69K -$152K -68.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 $782K $170K -$111K -39.5% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-30
Q3 2016 $893K $192K +$51K +36.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $842K $199K +$40K +25.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 $802K $221K +$57K +34.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q4 2015 $745K $281K -$353K -55.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 $1.1M $141K -$78K -35.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 $1.18M $159K -$24K -13.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $1.2M $164K -$23K -12.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 $1.22M $634K +$520K +456% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 $703K $219K +$122K +126% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $581K $183K +$109K +147% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-12
Q1 2014 $472K $187K +$115K +160% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
Q4 2013 $357K $114K +$21K +22.6% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 $336K $97K +$21K +27.6% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $315K $74K -$35K -32.1% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 $350K $72K -$30K -29.4% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $380K $93K Oct 1, 2012 Dec 31, 2012 10-K 2014-03-26
Q3 2012 $76K -$145K -65.6% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 $109K -$96K -46.8% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 $102K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q3 2011 $221K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-16
Q2 2011 $205K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.